Finding the relevance of antimicrobial stewardship for cystic fibrosis

Antimicrobial Resistance International Working Group in Cystic Fibrosis

Research output: Contribution to journalReview article

Abstract

Antimicrobials have undoubtedly improved the lives of people with CF, but important antimicrobial-related toxicities and the emergence of antimicrobial-resistant bacteria associated with their use must be considered. Antimicrobial stewardship (AMS) is advocated across the spectrum of healthcare to promote the appropriate use of antimicrobials to preserve their current effectiveness and to optimise treatment, and it is clear that AMS strategies are applicable to and can benefit both non-CF and CF populations. This perspective explores the definition and components of an AMS program, the current evidence for AMS, and the reasons why AMS is a challenging concept in the provision of CF care. We also discuss the elements of CF care which align with AMS programs and principles and propose research priorities for AMS in CF.

Original languageEnglish (US)
JournalJournal of Cystic Fibrosis
DOIs
StateAccepted/In press - Jan 1 2020

    Fingerprint

Keywords

  • Antimicrobial stewardship
  • Antimicrobials
  • Pulmonary Exacerbations

ASJC Scopus subject areas

  • Pediatrics, Perinatology, and Child Health
  • Pulmonary and Respiratory Medicine

Cite this

Antimicrobial Resistance International Working Group in Cystic Fibrosis (Accepted/In press). Finding the relevance of antimicrobial stewardship for cystic fibrosis. Journal of Cystic Fibrosis. https://doi.org/10.1016/j.jcf.2020.02.012